Log In
Print
BCIQ
Print
Print this Print this
 

PRX-110

  Manage Alerts
Collapse Summary General Information
Company Protalix BioTherapeutics Inc.
DescriptionInhaled recombinant human deoxyribonuclease 1 (DNase 1)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPreclinical
Standard IndicationCystic fibrosis (CF)
Indication DetailsTreat cystic fibrosis (CF)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today